Cell & Gene Meeting on the Mesa Phoenix USA Del 06/10/2025 to 08/10/2025 Healthcare Advanced therapies International
Corify Care secures €6 million to accelerate the expansion of its revolutionary non-invasi... 11/12/2024 Healthcare Advanced therapies Corify Care has secured €6 million in funding to expand its non-invasive cardiac mapping technology, ACORYS, aimed at... Partners - Corify Care
Eugin Group leads €3.5-million project to improve embryo implantation, a factor associate... 04/12/2024 Healthcare Advanced therapies The Eugin Group, from its Basic Research Centre at the Barcelona Science Park, is leading a consortium of 15 public and... Partners - Parc Científic de Barcelona
ORYZON continues to strengthen its patent portfolio for vafidemstat 02/12/2024 Healthcare Advanced therapies “Decision to grant” communication in Russia Partners - Oryzon Genomics
Access to Innovative Therapies in Spain: Challenges and Opportunities 07/11/2024 Healthcare Access to innovation Innovative drugs Advanced therapies International In this article, Chus Castillo, Partner Consulting Iberia at Alira Health, and Ion Arocena, General Manager at AseBio... Partners
Caszyme and Integra Therapeutics sign licensing agreement for novel CRISPR Cas12l nucleas... 05/11/2024 Healthcare Advanced therapies The agreement was unveiled at this year’s BIO Europe, which is the largest partnering event for the biomedical industry... Partners - Integra Therapeutics S.L.
ADmit Therapeutics predicts progression to Alzheimer's dementia 14 years in advance 28/10/2024 Healthcare Advanced therapies Partners - ADmit Therapeutics
ORYZON reports financial results and corporate update for quarter ended September 30, 2024 28/10/2024 Healthcare Advanced therapies Financing Final data from PORTICO, global Phase IIb vafidemstat trial in BPD,presented at the 37th ECNP annual conference in... Partners - Oryzon Genomics
AEMPS approves Peaches' clinical trial with selective secretomes to treat COVID-19-associa... 10/10/2024 Healthcare Innovative drugs Personalized medicine Advanced therapies Peaches starts its phase I-II pilot trial to obtain an advanced biologic drug that will help combat cytokine storm, a... Partners - PEACHES BIOTECH S.L.
